pSivida Corp (PSDV)’s Partner Alimera Sciences (ALIM) Announces an Agreement to Raise Capital to Fund the Development and Commercialization of ILUVIEN®
7/18/2012 9:55:37 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its partner Alimera Sciences disclosed an agreement for a $40 million equity financing. Alimera identified the development and commercialization of ILUVIEN® as an intended use of the net proceeds from the offering.
comments powered by